Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2660-2665

  Sacco, Maria Grazia ^a,c   Caniatti, Mario ^b   Catò, Enrica Mira ^a   Frattini, Annalisa ^a   Chiesa, Giulia ^b   Ceruti, Roberta ^b   Adorni, Fulvio ^a   Zecca, Luigi ^a   Scanziani, Eugenio ^b   Vezzoni, Paolo ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; GENE THERAPY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR VASCULARIZATION;

ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; GENE THERAPY; HUMANS; LIPOSOMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; PEPTIDE FRAGMENTS; PLASMINOGEN; RECEPTOR, ERBB-2; RECEPTORS, VIRUS;

EID: 0034657404     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Liotta, L. A., Stegg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
2. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
3. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
4. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
5. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung Carcinoma. Cell, 79: 315-328, 1994.
6. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Antagonism induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
7. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
8. Mauceri, H. J. Hanna, N. N., Beckett, M. A., Gorski, D. H., Staba, M. J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G. A., Sukhatme, V. P., Kufe, D. W., and Weichselbaum, R. R. Combined effects of angiostatin and ionizing radiation in antitumor therapy. Nature (Lond.), 394: 287-291, 1998.
9. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce drug resistance. Nature (Lond.), 390: 404-407, 1997.
10. Sacco, M. G. Mangiarini, L., Villa, A., Macchi, P., Barbieri, O., Sacchi, M. C., Monteggia, E., Fasolo, V., Vezzoni, P., and Clerici, L. Local regression of breast tumors following intrammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase. Gene Ther., 2: 493-497, 1995.
11. Augustin, H. G. Antiangiogenic tumour therapy: will it work? Trends Pharmacol. Sci., 19: 216-222, 1998.
12. Hanahan, D., Christofori, G., Naik, P., and Arbeit, J. Transgenic mouse models of tumor angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur. J. Cancer, 32A: 2386-2393, 1996.
13. Hanahan, D. Transgenic mice as probes into complex systems. Science (Washington DC), 246: 1265-1275, 1989.
14. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
15. Parangi, S. O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., and Hanahan, D. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002-2007, 1996.
16. Bergers, G., Javaherian, K., Lo, K. M., Folkman, J., and Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science (Washington DC), 284: 808-812, 1999.
17. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54: 105-115, 1998.
18. Lucchini, F. Sacco, M. G., Hu, N., Villa, A., Brown, J., Cesano, L., Mangiarini, L. Rindi, G., Kindl, S., Sessa, F., Vezzoni, P., and Clerici, L. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTV-Neu transgenic mice. Cancer Lett., 64: 203-209, 1992.
19. Sacco, M. G. Benedetti, S., Duflot-Dancer, A., Mesnil, M., Bagnasco, L., Strina, D., Fasolo, V., Villa, A., Macchi, P., Faranda, S., Vezzoni, P., and Finocchiaro, G. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retroviral-mediated HSV-TK transfer in vivo. Gene Ther., 3: 1151-1156, 1996.
20. Sacco, M. G. Barbieri, O., Piccini, D., Zoppé, M., Zucchi, I., Frattini, A., Villa, A., and Vezzoni, P. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice. Gene Ther., 5: 388-393, 1998.
21. Boggio, K., Nicoletti, G., Di Carlo, E., Cavallo, F., Landuzzi, L., Melani, C., Giovarelli, M., Rossi, I., Nanni, P., De Giovanni, C., Bouchard, P., Wolf, S., Modesti, A., Musiani, P., Lollini, P. L., Colombo, M. P., and Forni, G. Interleukin-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/Neu transgenic mice. J. Exp. Med., 188: 589-596, 1998.
22. Sacco, M. G., Benedetti, S., Mira Catò, E., Caniatti, M., Ceruti, R., Scanziani, E., Pirola, B., Villa, A., Finocchiaro, G., and Vezzoni, P. Retroviral-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice. Gene Ther., 6: 1893-1897, 1999.
23. Vecchi, A. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol., 63: 247-254, 1994.
24. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
25. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis -correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
26. Hansen, S., Grabau, D. A., Rose, C., Bak, M., and Sorensen, F. B. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab. Invest., 78: 1563-1573, 1998.
27. Liotta, L. A., Kleinerman, J., and Saidel, F. Quantitative relationship of intravascular tumor cells, lumor vessels, and pulmonary metastases following tumor implantation. Cancer Res., 34: 997-1004, 1974.
28. Gasparini, G., and Harris, A. L. Clinical importance of tumor angiogenesis in breast carcinoma: much more than a new prognostic factor. J. Clin. Oncol., 13: 765-782, 1995.
29. Cao, Y., O'Reilly, M. S., Marshall, B., Flynn, E., Ji, R. W., and Folkman, J. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest., 101: 1055-1063, 1998.
30. Griscelli, F. Li, H., Bennaceur-Griscelli, A., Soria, J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P., and Lu, H. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. USA, 95: 6367-6372, 1998.
31. Tanaka, T., Cao, Y., Folkman, J., and Fine, H. A. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res., 58: 3362-3369, 1998.
32. Blezinger, P. Wang, J., Gondo, M., Quezada, A., Mehrens, D., French, M., Singhal, A., Sullivan, S., Rolland, A., Ralston, R., and Min, W. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene Nat. Biotechnol., 17: 343-348, 1999.
33. Chen, Q. R., Kumar, D., Stass, S. A., and Mixson, A. J. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res., 59: 3308-3312, 1999.
34. Cohen, J. Behind the headlines of endostatin's ups and downs. Science, 283: 1250-1251, 1999.
35. Lasic, D. D. Novel applications of liposomes. Trends Biotechnol., 16: 307-321, 1998.
36. Paillard, F. Cancer cells under the fire of combined therapies. Hum. Gene Ther., 9: 1259-1260, 1998.